Table 2.
Subgroup analysis of LINC-PINT expression an OS in cancer patients.
| Subgroup analysis | No. of studies | No. of patients | Pooled HR (96% CI) | P | Hetarogeneity | Model | |
|---|---|---|---|---|---|---|---|
| I2 (%) | P value | ||||||
| OS | 8 | 911 | 1.50 (1.17,1.93) | 0.002 | 0 | 0.84 | Fixed |
| Follow-up time | |||||||
| ≥ 5 years | 7 | 881 | 1.49 (1.16, 1.92) | 0.002 | 0 | 0.76 | Fixed |
| < 5 years | 1 | 30 | 2.09 (0.19, 22.99) | 0.55 | 0 | 0 | Fixed |
| Tumor type | |||||||
| Digestive system cancer | 5 | 611 | 1.46 (1.10, 1.94) | 0.008 | 0 | 0.56 | Fixed |
| Others | 3 | 300 | 1.65 (0.94, 2.87) | 0.08 | 0 | 0.85 | Fixed |
| Number of patients | |||||||
| ≥ 80 | 4 | 670 | 1.37 (1.01, 1.85) | 0.04 | 0 | 0.60 | Fixed |
| < 80 | 4 | 241 | 1.83 (1.17, 2.87) | 0.008 | 0 | 0.92 | Fixed |
| Therapy | |||||||
| Surgery | 7 | 839 | 1.48 (1.13, 1.92) | 0.004 | 0 | 0.77 | Fixed |
| Combined | 1 | 72 | 1.73 (0.78, 3.84) | 0.18 | 0 | 0 | Fixed |